These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7901531)

  • 41. The Oklahoma-Pittsburgh experience with interferon alpha in the treatment of HCV disease.
    Van Thiel DH; Friedlander L; Fagiuoli S; Molloy P; Kania RJ; Wright H
    J Okla State Med Assoc; 1995 Apr; 88(4):154-61. PubMed ID: 7782963
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of chronic hepatitis C with interferon alpha.
    Ross AG; Burt MJ; Jennings LC; Collett JA; Walford EJ; Chambers ST; Chapman BA
    N Z Med J; 1995 Mar; 108(996):101-3. PubMed ID: 7715872
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: a comparison.
    Tong MJ; Blatt LM; McHutchison JG; Co RL; Conrad A
    Hepatology; 1997 Dec; 26(6):1640-5. PubMed ID: 9398010
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa.
    Cacciarelli TV; Martinez OM; Gish RG; Villanueva JC; Krams SM
    Hepatology; 1996 Jul; 24(1):6-9. PubMed ID: 8707283
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of alpha-glutathione S-transferase in the monitoring of hemodialysis patients with hepatitis C virus infection undergoing high-dose interferon-alpha-2b therapy.
    Boran M; Cetin S
    Nephron; 1999; 82(1):22-6. PubMed ID: 10224480
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.
    Lau JY; Davis GL; Kniffen J; Qian KP; Urdea MS; Chan CS; Mizokami M; Neuwald PD; Wilber JC
    Lancet; 1993 Jun; 341(8859):1501-4. PubMed ID: 8099380
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serial quantitation of serum core protein and viral RNA of hepatitis C virus after interferon therapy: increase in viral loads in biochemical responders.
    Yoshioka K; Aiyama T; Iwata K; Yano M; Okumura A; Ishikawa T; Kakumu S
    Am J Gastroenterol; 1997 Aug; 92(8):1305-9. PubMed ID: 9260795
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatitis C virus replication in liver and peripheral blood mononuclear cells of interferon-alpha-treated and untreated patients with chronic hepatitis C.
    Yun ZB; Sönnerborg A; Weiland O
    Scand J Gastroenterol; 1994 Jan; 29(1):82-6. PubMed ID: 8128182
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interferon treatment for hepatitis C virus infection in patients on haemodialysis.
    Chan TM; Wu PC; Lau JY; Lok AS; Lai CL; Cheng IK
    Nephrol Dial Transplant; 1997 Jul; 12(7):1414-9. PubMed ID: 9249778
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The fluctuations of hepatitis C virus RNA and IgM anti-HCV (core) serum levels correlate with those of alanine aminotransferases during the hepatitis relapses of patients treated with interferon.
    Negro F; Abate ML; Mondardini A; Baldi M; Leandro G; Lombardi S; Wolfe L; Ryff JC; Verme G; Brunetto MR
    J Viral Hepat; 1995; 2(4):171-4. PubMed ID: 7489343
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapy of hepatitis C: patients with normal aminotransferase levels.
    Marcellin P; Lévy S; Erlinger S
    Hepatology; 1997 Sep; 26(3 Suppl 1):133S-136S. PubMed ID: 9305678
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Disappearance of hepatitis C virus RNA in plasma during interferon alpha-2B treatment in hemophilia patients.
    Bresters D; Mauser-Bunschoten EP; Cuypers HT; Lelie PN; Han JH; Jansen PL; Houghton M; Reesink HW
    Scand J Gastroenterol; 1992; 27(3):166-8. PubMed ID: 1323873
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interferon alfa therapy in patients with chronic hepatitis C and persistently normal aminotransferase activity.
    Serfaty L; Chazouillères O; Pawlotsky JM; Andreani T; Pellet C; Poupon R
    Gastroenterology; 1996 Jan; 110(1):291-5. PubMed ID: 8536870
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of interferon therapy in patients with chronic hepatitis C. Comparison between non-drinkers and drinkers.
    Okazaki T; Yoshihara H; Suzuki K; Yamada Y; Tsujimura T; Kawano K; Yamada Y; Abe H
    Scand J Gastroenterol; 1994 Nov; 29(11):1039-43. PubMed ID: 7871371
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Virological response to interferon treatment in hepatitis C virus carriers with normal aminotransferase levels and chronic hepatitis.
    Rossini A; Ravaggi A; Biasi L; Agostinelli E; Bercich L; Gazzola GB; Callea F; Radaeli E; Cariani E
    Hepatology; 1997 Oct; 26(4):1012-7. PubMed ID: 9328328
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interferon therapy in hemodialysis patients with chronic hepatitis C virus infection induces a high rate of long-term sustained virological and biochemical response.
    Espinosa M; Rodriguez M; Martin-Malo A; Alvarez de Lara MA; Gonzalez R; Lopez-Rubio F; de la Mata M; Aljama P
    Clin Nephrol; 2001 Mar; 55(3):220-6. PubMed ID: 11316242
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term biochemical and virological response to natural interferon-alpha in patients with chronic hepatitis C.
    Hagiwara H; Hayashi N; Kasahara A; Oshita M; Katayama K; Naito M; Masuzawa M; Yoshihara H; Shimizu Y; Fusamoto H; Kamada T
    Dig Dis Sci; 1996 May; 41(5):1001-7. PubMed ID: 8625742
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors affecting treatment responses to interferon-alpha in chronic hepatitis C.
    Pawlotsky JM; Roudot-Thoraval F; Bastie A; Darthuy F; Rémiré J; Métreau JM; Zafrani ES; Duval J; Dhumeaux D
    J Infect Dis; 1996 Jul; 174(1):1-7. PubMed ID: 8655978
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term clinical and virological outcomes of chronic hepatitis C after successful interferon therapy.
    Tsuda N; Yuki N; Mochizuki K; Nagaoka T; Yamashiro M; Omura M; Hikiji K; Kato M
    J Med Virol; 2004 Nov; 74(3):406-13. PubMed ID: 15368524
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A prospective, randomized trial comparing lymphoblastoid to recombinant interferon alfa 2a as therapy for chronic hepatitis C.
    Rumi M; Del Ninno E; Parravicini ML; Romeo R; Soffredini R; Donato MF; Wilber J; Russo A; Colombo M
    Hepatology; 1996 Dec; 24(6):1366-70. PubMed ID: 8938163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.